Veterinary Medicines

Covexin 8 vet. injeksjonsvæske, suspensjon Vaksine mot klostridieinfeksjoner til sau og storfe (inaktivert, adsorbert)

Not authorised
  • Clostridium tetani, toxoid
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Clostridium haemolyticum, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium chauvoei, Inactivated
Download as PDF

Product identification

Medicine name:
Covexin 8 vet. injeksjonsvæske, suspensjon Vaksine mot klostridieinfeksjoner til sau og storfe (inaktivert, adsorbert)
Active substance:
  • Clostridium tetani, toxoid
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Clostridium haemolyticum, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium chauvoei, Inactivated
Target species:
  • Sheep
  • Cattle
  • Sheep (lamb)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium tetani, toxoid
    1.60
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium novyi, toxoid
    2.10
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.80
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium haemolyticum, toxoid
    11.70
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    7.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B and C, beta toxoid
    13.10
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    90.00
    percentage protection
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • All relevant tissues
        0
        day
    • Cattle
      • All relevant tissues
        0
        day
    • Sheep (lamb)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI04AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis Finland Oy
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 95-3537
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 16/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."